At Genaphora, we develop a proprietary technology for advanced molecular diagnostics kits, dramatically improving assay efficiency and accuracy, by lowering diagnostic cycles from days to hours, with the highest sensitivity and cost-effectiveness. Genaphora is positioned to become a significant player in the fast growing market of molecular diagnostics by introducing innovative, computational-biology-derived products and solutions to emerging markets worldwide.
Looking for a particular Genaphora employee's phone or email?
The Genaphora annual revenue was $5 million in 2026.
Genaphora is based in Tel Aviv, Tel Aviv.
The NAICS codes for Genaphora are [541713, 54, 54171, 541, 5417].
The SIC codes for Genaphora are [87, 873].